Cargando…

Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?

Natural killer (NK) cells are involved in innate immune responses to viral infections either via direct cytotoxicity which destroys virus-infected cells or production of immunoregulatory cytokines which modulate adaptive immunity and directly inhibit virus replication. These functions are mediated b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondelli, Mario U., Oliviero, Barbara, Mele, Dalila, Mantovani, Stefania, Gazzabin, Chiara, Varchetta, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572686/
https://www.ncbi.nlm.nih.gov/pubmed/23420385
http://dx.doi.org/10.3389/fimmu.2012.00351
_version_ 1782259345125277696
author Mondelli, Mario U.
Oliviero, Barbara
Mele, Dalila
Mantovani, Stefania
Gazzabin, Chiara
Varchetta, Stefania
author_facet Mondelli, Mario U.
Oliviero, Barbara
Mele, Dalila
Mantovani, Stefania
Gazzabin, Chiara
Varchetta, Stefania
author_sort Mondelli, Mario U.
collection PubMed
description Natural killer (NK) cells are involved in innate immune responses to viral infections either via direct cytotoxicity which destroys virus-infected cells or production of immunoregulatory cytokines which modulate adaptive immunity and directly inhibit virus replication. These functions are mediated by different NK subpopulations, with cytotoxicity being generally performed by CD56(dim) NK cells, whereas CD56(bright) NK cells are mainly involved in cytokine secretion. NK functional defects are usually combined so that impaired degranulation is often associated with deficient cytokine production. Innate immunity is thought to be relevant in the control of hepatitis virus infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV), and recent findings reproducibly indicate that NK cells in chronic viral hepatitis are characterized by a functional dichotomy, featuring a conserved or enhanced cytotoxicity and a reduced production of interferon (IFN)-γ and tumor necrosis factor-α. In chronic HCV infection this appears to be caused by altered IFN-α signaling resulting from increased signal transducer and activator of transcription 1 (STAT1) phosphorylation, which polarizes NK cells toward cytotoxicity, and a concomitantly reduced IFN-α induced STAT4 phosphorylation yielding reduced IFN-γ mRNA levels. These previously unappreciated findings are compatible on the one hand with the inability to clear HCV and HBV from the liver and on the other they may contribute to understand why these patients are often resistant to IFN-α-based therapies.
format Online
Article
Text
id pubmed-3572686
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-35726862013-02-15 Natural killer cell functional dichotomy: a feature of chronic viral hepatitis? Mondelli, Mario U. Oliviero, Barbara Mele, Dalila Mantovani, Stefania Gazzabin, Chiara Varchetta, Stefania Front Immunol Immunology Natural killer (NK) cells are involved in innate immune responses to viral infections either via direct cytotoxicity which destroys virus-infected cells or production of immunoregulatory cytokines which modulate adaptive immunity and directly inhibit virus replication. These functions are mediated by different NK subpopulations, with cytotoxicity being generally performed by CD56(dim) NK cells, whereas CD56(bright) NK cells are mainly involved in cytokine secretion. NK functional defects are usually combined so that impaired degranulation is often associated with deficient cytokine production. Innate immunity is thought to be relevant in the control of hepatitis virus infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV), and recent findings reproducibly indicate that NK cells in chronic viral hepatitis are characterized by a functional dichotomy, featuring a conserved or enhanced cytotoxicity and a reduced production of interferon (IFN)-γ and tumor necrosis factor-α. In chronic HCV infection this appears to be caused by altered IFN-α signaling resulting from increased signal transducer and activator of transcription 1 (STAT1) phosphorylation, which polarizes NK cells toward cytotoxicity, and a concomitantly reduced IFN-α induced STAT4 phosphorylation yielding reduced IFN-γ mRNA levels. These previously unappreciated findings are compatible on the one hand with the inability to clear HCV and HBV from the liver and on the other they may contribute to understand why these patients are often resistant to IFN-α-based therapies. Frontiers Media S.A. 2012-11-26 /pmc/articles/PMC3572686/ /pubmed/23420385 http://dx.doi.org/10.3389/fimmu.2012.00351 Text en Copyright © Mondelli, Oliviero, Mele, Mantovani, Gazzabin and Varchetta. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Immunology
Mondelli, Mario U.
Oliviero, Barbara
Mele, Dalila
Mantovani, Stefania
Gazzabin, Chiara
Varchetta, Stefania
Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title_full Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title_fullStr Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title_full_unstemmed Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title_short Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
title_sort natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572686/
https://www.ncbi.nlm.nih.gov/pubmed/23420385
http://dx.doi.org/10.3389/fimmu.2012.00351
work_keys_str_mv AT mondellimariou naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis
AT olivierobarbara naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis
AT meledalila naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis
AT mantovanistefania naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis
AT gazzabinchiara naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis
AT varchettastefania naturalkillercellfunctionaldichotomyafeatureofchronicviralhepatitis